Central pontine myelinolysis after orthotopic liver transplant-a rare complication

Experimental and Clinical Transplantation

Volumn 8, Issue 4, 2010, Pages 321-324

  Al Sarraf, Ahmad J ^a   Haque, Mazhar ^a   Pudek, Morris ^b   Yoshida, Eric M ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b VANCOUVER GENERAL HOSPITAL   (Canada)

Author keywords

Hypernatremia; Hyponatremia; Neurologic complication

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; SODIUM; STEROID;

ADULT; ARTERY THROMBOSIS; ARTICLE; ASIAN; CASE REPORT; CENTRAL PONTINE MYELINOLYSIS; COMPUTER ASSISTED TOMOGRAPHY; DYSPHASIA; ELECTROENCEPHALOGRAPHY; FEMALE; GRAFT FAILURE; HEPATIC ARTERY THROMBOSIS; HEPATIC ENCEPHALOPATHY; HUMAN; HYPERNATREMIA; KIDNEY DYSFUNCTION; LETHARGY; LIVER CIRRHOSIS; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; NUCLEAR MAGNETIC RESONANCE IMAGING; QUADRIPLEGIA; REOPERATION; SODIUM BLOOD LEVEL;

FEMALE; HUMANS; HYPERNATREMIA; LIVER TRANSPLANTATION; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; MYELINOLYSIS, CENTRAL PONTINE; RISK ASSESSMENT; RISK FACTORS; SODIUM; TIME FACTORS;

EID: 78650537541     PISSN: 13040855     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Kim BS, Lee SG, Hwang S, Park KM, Kim KH, Ahn CS, et al. Neurologic complications in adult living donor liver transplant recipients. Clin Transplant. 2007;21(4):544-547.
2. Adams RD, Victor M, Mancall EL. Central pontine myelinolysis: a hitherto undescribed disease occurring in alcoholic and malnourished patients. AMA Arch Neurol Psychiatry. 1959;81(2):154-172.
3. Starzl TE, Schneck SA, Mazzoni G, Aldrete JA, Porter KA, Schröter GP, et al. Acute neurological complications after liver transplantation with particular reference to intraoperative cerebral air embolus. Ann Surg. 1978;187(3):236-240.
4. Ardizzone G, Arrigo A, Schellino MM, Stratta C, Valzan S, Skurzak S, et al. Neurological complications of liver cirrhosis and orthotopic liver transplant. Transplant Proc. 2006;38(3):789-792.
5. Soupart A, Ngassa M, Decaux G. Therapeutic relowering of the serum sodium in a patient after excessive correction of hyponatremia. Clin Nephrol. 1999;51(6):383-386.
6. Brown WD. Osmotic demyelination disorders: central pontine and extrapontine myelinolysis. Curr Opin Neurol. 2000;13(6):691-697.
7. Boon AP, Carey MP, Adams DH, Buckels J, McMaster P. Central pontine myelinolysis in liver transplantation. J Clin Pathol. 1991;44(11):909-914.
8. Estol CJ, Faris AA, Martinez AJ, Ahdab-Barmada M. Central pontine myelinolysis after liver transplantation. Neurology. 1989;39(4):493-498.
9. Bramhall SR, Minford E, Gunson B, Buckels JA. Liver transplantation in the UK. World J Gastroenterol. 2001;7(5):602-611.
10. Tien R, Arieff AI, Kucharczyk W, Wasik A, Kucharczyk J. Hyponatremic encephalopathy: is central pontine myelinolysis a component? Am J Med. 1992;92(5):513-522.
11. Mast H, Gordon PH, Mohr JP, Tatemichi TK. Central pontine myelinolysis: clinical syndrome with normal serum sodium. Eur J Med Res. 1995;1(3):168-170.
12. Wszolek ZK, McComb RD, Pfeiffer RF, Steg RE, Wood RP, Shaw BW Jr, et al. Pontine and extrapontine myelinolysis following liver transplantation. Relationship to serum sodium. Transplantation. 1989;48(6):1006-1012.
13. Lee EM, Kang JK, Yun SC, Kim KH, Kim SJ, Hwang KS, et al. Risk factors for central pontine and extrapontine myelinolysis following orthotopic liver transplantation. Eur Neurol. 2009;62(6):362-268.
14. Yu J, Zheng SS, Liang TB, Shen Y, Wang WL, Ke QH. Possible causes of central pontine myelinolysis after liver transplantation. World J Gastroenterol. 2004;10(17):2540-2543.
15. Ashrafian H, Davey P. A review of the causes of central pontine myelinosis: yet another apoptotic illness? Eur J Neurol. 2001;8(2):103-109.
16. Taneja K, Sabharwal RK, Taneja A, Mukherjee M. Central pontine myelinolysis in a normonatremic child. Indian Pediatr. 1997;34(2):153-156.
17. Mast H, Gordon PH, Mohr JP, Tatemichi TK. Central pontine myelinolysis: clinical syndrome with normal serum sodium. Eur J Med Res. 1995;1(3):168-170.
18. Dunn CJ, Wagstaff AJ, Perry CM, Plosker GL, Goa KL. Cyclosporin: an updated review of the pharmacokinetic properties, clinical efficacy and tolerability of a microemulsion-based formulation (neoral)1 in organ transplantation. Drugs. 2001;61(13):1957-2016.
19. Sterns RH, Cappuccio JD, Silver SM, Cohen EP. Neurologic sequelae after treatment of severe hyponatremia: a multicenter perspective.J Am Soc Nephrol. 1994;4(8):1522-1530.
20. Huq S, Wong M, Chan H, Crimmins D. Osmotic demyelination syndromes: central and extrapontine myelinolysis. J Clin Neurosci. 2007;14(7):684-688.
21. Bronster DJ, Emre S, Boccagni P, Sheiner PA, Schwartz ME, Miller CM. Central nervous system complications in liver transplant recipients--incidence, timing, and long-term follow-up. Clin Transplant. 2000;14(1):1-7.
22. Go M, Amino A, Shindo K, Tsunoda S, Shiozawa Z. A case of central pontine myelinolysis and extrapontine myelinolysis during rapid correction of hypernatremia[in Japanese]. Rinsho Shinkeigaku. 1994;34(11):1130-1135.
23. Bird GL, Meadows J, Goka J, Polson R, Williams R. Cyclosporinassociated akinetic mutism and extrapyramidal syndrome after liver transplantation. J Neurol Neurosurg Psychiatry. 1990;53(12):1068-1071.
24. Abbasoglu O, Goldstein RM, Vodapally MS, Jennings LW, Levy MF, Husberg BS, et al. Liver transplantation in hyponatremic patients with emphasis on central pontine myelinolysis. Clin Transplant. 1998;12(3):263-269.